Cerebral toxoplasmosis associated with the use of immunosuppressive treatments

Rev Soc Bras Med Trop. 2022 Apr 8:55:e07202021. doi: 10.1590/0037-8682-0720-2021. eCollection 2022.

Authors

Ivone Melo Valadão¹, Ana Sofia Sequeira¹, Vanessa Barcelos¹

Affiliation

¹ Hospital Santo Espírito da Ilha Terceira, Internal Medicine Department, Angra do Heroísmo, Azores, Portugal.

No abstract available

MeSH terms

Humans
Immunosuppressive Agents / adverse effects
Toxoplasmosis, Cerebral* / drug therapy

Substances

Immunosuppressive Agents